Achieve Life Sciences
ACHV· Manufacturing· Fiscal year ends in December
No proxy on file names the CEO of Achieve Life Sciences.
Executives3
See all- 1Richard StewartFormer Chief Executive OfficerFY2025
- 2Erik AtkissonChief Legal OfficerFY2025
- 3Jaime XinosFormer Chief Commercial OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allAchieve Life Sciences paid its 3 named executives $3.3M in total in FY2025 (Dec).
| Name | |||
|---|---|---|---|
| Richard StewartFormer Chief Executive Officer | |||
| Erik AtkissonChief Legal Officer | Not disclosed | Not disclosed | |
| Jaime XinosFormer Chief Commercial Officer | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Achieve Life Sciences. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board5
See all- Thomas SelligDirector · 2 yr on the boardIndependentAudit, Nominating and Governance (Chair)—Paid as an executive
- Nancy R. PhelanDirector · 0 yr on the boardIndependentAudit—Paid as an executive
- Chris MartinDirector · -1 yr on the boardIndependentCompensation—Paid as an executive
- Jeffrey FarrowDirector · -1 yr on the boardIndependentAudit (Chair), Nominating and Governance—Paid as an executive
- Reid WaldmanDirector · -1 yr on the boardIndependentCompensation (Chair)—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Jun 8, 2026 | FY2025 |
| Annual report | 10-K | Mar 24, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 28, 2025 | FY2024 |
| Annual report | 10-K | Mar 11, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 26, 2024 | FY2023 |
| Annual report | 10-K | Mar 28, 2024 | FY2023 |
